Dexamethasone intravitreal implant for macular edema: a pilot study in a public health center
Introduction: Macula edema consists in one of the most common causes of visual impairment. Objective: To evaluate the safety and efficacy of continuous release of 0.7 mg dexamethasone (using implantable device) for treatment of macular edema. Methods: Cross-sectional observational study of 16 patien...
Main Authors: | Maria Júlia Izzo Crespo, Cristina Nery Carbajo, Glaucia Luciano da Veiga, Fernando Luiz Affonso Fonseca, Vagner Loduca Lima, Júlio Zaki Abucham Neto |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina do ABC
2020-12-01
|
Series: | ABCS Health Sciences |
Subjects: | |
Online Access: | https://www.portalnepas.org.br/abcshs/article/view/1851 |
Similar Items
-
Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy
by: Barbara Burgos-Blasco, et al.
Published: (2020-06-01) -
Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
by: Ali Osman Saatci, et al.
Published: (2013-03-01) -
Intravitreal Dexamethasone Implant for the Treatment of Patient with Resistant to Anti-VEGF Diabetic Macular Edema
by: M. M. Bikbov, et al.
Published: (2020-08-01) -
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
by: Chang Ki Yoon, et al.
Published: (2021-01-01) -
Widening use of dexamethasone implant for the treatment of macular edema
by: Bonfiglio V, et al.
Published: (2017-08-01)